2-NAPHTHALENECARBOXAMIDE, 4-(2-(3-CHLORO-2-METHYLPHENYL)DIAZENYL)-N-(4-((4-(((4-(2-(3-CHLORO-2-METHYLPHENYL)DIAZENYL)-3-HYDROXY-2-NAPHTHALENYL)CARBONYL)AMINO)BENZOYL)AMINO)PHENYL)-3-HYDROXY-
UNII WMG36S2AX8
Substance Identification & Data
This profile provides standardized clinical and technical data for 2-naphthalenecarboxamide, 4-(2-(3-chloro-2-methylphenyl)diazenyl)-n-(4-((4-(((4-(2-(3-chloro-2-methylphenyl)diazenyl)-3-hydroxy-2-naphthalenyl)carbonyl)amino)benzoyl)amino)phenyl)-3-hydroxy-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WMG36S2AX8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 56418-72-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C49H35Cl2N7O5 JEHUFDCZTMGLEA-NCCSDIRBSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 2-naphthalenecarboxamide, 4-(2-(3-chloro-2-methylphenyl)diazenyl)-n-(4-((4-(((4-(2-(3-chloro-2-methylphenyl)diazenyl)-3-hydroxy-2-naphthalenyl)carbonyl)amino)benzoyl)amino)phenyl)-3-hydroxy-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.